ERFIP2013

2013 Epilepsy Research Forum

Coordinatore	CHANCEL LIMITED    more  Organization address address: PRIORY HALL 7 city: STILLORGAN postcode: CO contact info Titolo: Mr. Nome: Eoin Cognome: Sheanon Email: send email Telefono: 35312056720
Nazionalità Coordinatore	Ireland [IE]
Totale costo	255˙501 €
EC contributo	100˙000 €
Programma	FP7-HEALTH Specific Programme "Cooperation": Health
Code Call	FP7-HEALTH-2012-INNOVATION-1
Funding Scheme	CSA-SA
Anno di inizio	2012
Periodo (anno-mese-giorno)	2012-07-01   -   2013-12-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	CHANCEL LIMITED  Organization address address: PRIORY HALL 7 city: STILLORGAN postcode: CO contact info Titolo: Mr. Nome: Eoin Cognome: Sheanon Email: send email Telefono: 35312056720	IE (STILLORGAN)	coordinator	100˙000.00
2	INTERNATIONAL BUREAU FOR EPILEPSY INC NON PROFIT CORPORATION  Organization address address: 15TH STREET 1015 NW SUITE 1000 city: WASHINGTON DC postcode: 20005 contact info Titolo: Ms. Nome: Ann Cognome: Little Email: send email Telefono: 35312108850	US (WASHINGTON DC)	participant	0.00
3	INTERNATIONAL LEAGUE AGAINST EPILEPSY  Organization address address: NORTH MAIN STREET 342 city: WEST HARTFORD CT postcode: 06117 2507 contact info Titolo: Prof. Nome: Emilio Cognome: Perucca Email: send email Telefono: 39038222741	US (WEST HARTFORD CT)	participant	0.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Epilepsy is a brain disorder that is characterised by recurrent episodes of cerebral dysfunction, that is, seizures which are caused by excessive electrical discharges of nerve cells. It is one of the most common serious disorders of the brain. Six million people in Europe have Epilepsy and approximately 300,000 new cases are diagnosed each year. The Epilepsy Research Forum 2013 will seek to contribute to the debate on the coordination of research at national and European Union level as well and to focus on research achievements made to date and the opportunities for further advances. By bringing together a wide spectrum of stakeholders it is hoped that national and European epilepsy research networks will be better coordinated and targeted. With an expected attendance of 500 stakeholders, the Conference will stimulate debate on, in the first instance, promoting research into improving the diagnosis and treatment of epilepsy. The Conference programme will also aim at improving awareness and reducing stigma, in what will essentially be a multifaceted conference engaging clinicians and patients alike.

The specific objectives are:

-to promote and discuss the opportunities for coordinated, targeted and precise innovative research efforts that would build on the significant gains made by basic and clinical research in the past

-the 2013 Forum, whilst aimed primarily at facilitating research opportunities in epilepsy, will also seek to address the optimal standards of care for people with epilepsy which are still unequally distributed in European Union'

Introduzione (Teaser)

Epilepsy is a neurological disorder characterised by seizures and that affects millions of people globally. Epileptic patients have poor quality of life and suffer from social stigma.